Enzon Pharms Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENZN | AZN | AMGN | GILD | VRTX |
| Company | Enzon Pharms Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0595 | 204.20 | 351.70 | 140.96 | 444.15 |
| High | 0.0606 | 204.39 | 352.60 | 140.96 | 447.82 |
| Low | 0.0450 | 199.50 | 344.21 | 138.06 | 437.19 |
| Latest | 0.0588 | 201.21 | 348.22 | 139.77 | 441.70 |
| Change | -0.0012 | -3.17 | -2.73 | -0.68 | -2.58 |
| % Change | -2.00% | -1.55% | -0.78% | -0.48% | -0.58% |
| Volume | 325,400 | 1,657,800 | 2,140,000 | 3,790,500 | 1,459,400 |
| 20-Day Average Volume | 76,525 | 1,911,475 | 2,786,240 | 6,075,375 | 1,338,685 |
| Previous Close | 0.0600 | 204.38 | 350.95 | 140.45 | 444.28 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0596 | 195.49 | 349.67 | 139.05 | 445.01 |
| 20-Day Raw Stochastic | 78.21% | 75.55% | 51.36% | 59.36% | 42.48% |
| 20-Day Relative Strength | 49.44 | 55.03 | 45.50 | 48.32 | 45.48 |
| Weighted Alpha | -62.39 | +47.39 | +24.37 | +32.95 | -5.73 |
| Today's Opinion | 56% Sell | 88% Buy | 24% Buy | 56% Buy | 8% Buy |
| Previous Opinion | 8% Sell | 88% Buy | 56% Buy | 56% Buy | 8% Buy |
| Last Month's Opinion | 8% Sell | 56% Buy | 88% Buy | 88% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +17.60% since 03/16/26 | -1.50% since 04/08/26 | -0.45% since 04/08/26 | -1.25% since 04/08/26 | -0.50% since 04/08/26 |
| Low | 0.0450 on 03/24/26 | 199.49 on 04/15/26 | 344.21 on 04/15/26 | 137.02 on 04/13/26 | 433.68 on 04/13/26 |
| High | 0.0680 on 03/20/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 447.82 on 04/15/26 |
| 1-Month | |||||
| %Chg | -17.18% since 02/24/26 | +5.96% since 03/13/26 | -4.91% since 03/13/26 | -3.60% since 03/13/26 | -5.89% since 03/13/26 |
| Low | 0.0150 on 03/09/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 425.26 on 04/07/26 |
| High | 0.0680 on 03/20/26 | 207.30 on 04/10/26 | 370.89 on 03/16/26 | 146.71 on 03/17/26 | 476.17 on 03/16/26 |
| 3-Month | |||||
| %Chg | +39.34% since 12/24/25 | +7.04% since 01/15/26 | +5.51% since 01/15/26 | +15.26% since 01/15/26 | +0.63% since 01/15/26 |
| Low | 0.0150 on 03/09/26 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 122.10 on 01/16/26 | 425.26 on 04/07/26 |
| High | 0.0790 on 02/02/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| 6-Month | |||||
| %Chg | -26.04% since 09/24/25 | +18.60% since 10/15/25 | +17.12% since 10/15/25 | +18.15% since 10/15/25 | +8.29% since 10/15/25 |
| Low | 0.0150 on 03/09/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 403.16 on 11/04/25 |
| High | 0.0845 on 10/08/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,364 | 316,974,592 | 189,402,464 | 174,329,632 | 113,007,056 |
| Shares Outstanding, K | 74,215 | 1,550,908 | 539,685 | 1,241,222 | 254,360 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -3,410,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 3,190,000,000 |
| Last Quarter Net Income | -1,070,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,191,100,000 |
| 60-Month Beta | 0.20 | 0.35 | 0.47 | 0.39 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 03/02/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | 05/08/26 | 04/29/26 | 04/30/26 | 05/07/26 | 05/04/26 |
| Most Recent Dividend | 0.240 on 09/30/19 | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | N/A |
| Next Ex-Dividends Date | 09/30/19 | 02/20/26 | 05/15/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.08 | 16.01 | 17.06 | 26.80 |